Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Formin binding protein 1 pseudogene 1 (FNBP1P1) is a pseudogene, meaning it is a DNA sequence similar to a known gene (FNBP1) but is generally considered non-functional since it does not code for a protein product. Pseudogenes like FNBP1P1 may arise from duplication or retrotransposition of the parent gene and typically do not have a direct role in cellular processes, serve as therapeutic targets, or produce functional proteins. There is no evidence that FNBP1P1 acts as a therapeutic target or molecular receptor, and it is not listed in major gene or drug-target databases as having functional or clinical significance[9]. Context and clarification: - *FNBP1* (formin binding protein 1), by contrast, is a well-studied protein-coding gene involved in actin cytoskeleton regulation and has emerging roles in cancer cell invasion and motility[1][2][3][4], but **FNBP1P1 is not FNBP1**. - No search results indicate that FNBP1P1 codes for a protein, is a drug target, or has any aliases or established biological function. - Some literature lists pseudogenes as possible regulators of coding gene expression via RNA interference or competing endogenous RNA (ceRNA) networks, but there is no such evidence specifically for FNBP1P1 in the available results or major databases reviewed here. Summary of target status: - FNBP1P1 is a **pseudogene**, not a receptor, enzyme, transporter, or other classical drug target. - There is nothing to suggest FNBP1P1 is a misspelled, missing, or ambiguous entry; it simply is not a bona fide drug or therapeutic target, and the query appears to conflate the protein-coding gene (FNBP1) with its pseudogene. If you require information on the active gene/protein **formin binding protein 1 (FNBP1/FBP17)**, which is a genuine target with roles in cell motility and cancer, please clarify, as nearly all available information relates to FNBP1, not its pseudogene.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formin binding protein 1 pseudogene 1 (FNBP1P1).